Summary of Purpose
This study tested the effect of the HMG-CoA reductase inhibitor, lovastatin, on early-stage carotid atherosclerosis (as detected by B-mode ultrasonography) in 919 asymptomatic men and women, 40-79 years of age with moderately elevated LDL cholesterol.Read More →
The following dates are available for this trial. Trial information last updated on 3 August 2000.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Double-blind, placebo-controlled, factorially designed study of 919 patients.